The 6th International Conference on Biomedical Engineering and Bioinformatics for Health is an essential global platform for the presentation and discussion of cutting-edge research and innovations in the fields of biomedical engineering, bioinformatics, and health sciences, which will bring together global leaders and innovators from academia, medical institutions, and the industry. The first five editions of the International Conference on Biomedical Engineering and Bioinformatics for Health (ICBEBH) have demonstrated a successful history in conference organization and a commitment to ongoing evolution. The series began with the 2019 Workshop on Cancer and Biomarkers, which was followed by the 2021 Workshop on Cancer and Biomarkers, showing a consistent focus on this critical area. The scope then expanded to encompass a wider range of diseases with the 2022 Workshop on Diseases and Biomarkers. This expansion continued with the 2023 Workshop on Diseases and Biomarkers, which further built upon the established foundation. The 2024 5th International Workshop on Diseases and Biomarkers marked a significant milestone in the conference series. Carrying forward the tradition and learning from these positive experiences, the upcoming conference is set to continue the development of this esteemed series of events.

Important Dates

• Full Paper Submission Date: May 6, 2025
• Notification of Acceptance Date: June 1, 2025
• Final Paper Submission Date: June 20, 2025
• Registration Deadline: July 5, 2025
• Conference Date: July 19-21, 2025

Submission Guidelines

1. Papers for publication must be submitted in full paper electronically. All edition and update must be done up until the submission deadline.

2. The authors are suggested to use the Formatting Template to meet formatting requirements (IEEE Template). Your paper must comply with the following specifications: 

• Paper Length: Each paper should be within 4-8 pages, each registration covers 5 pages, for extra pages, fee will be charged
• Official language is English in paper writing and presenting

3. Submissions to ICBEBH 2025 should report on significant, original, and previously unpublished results. All submissions will be subjected to double-blind peer reviews, who are expert or have been experiencing in the related field for years. The accepted papers must be revised, taking into consideration the referees' comments and suggestions, before inclusion in the conference proceedings.

4. At least one of the authors listed on the accepted paper must pay the registration and make a presentation on-site. 

List of Topics

• Topic 1: Molecular Imaging

1. Advanced imaging techniques and technologies

2. Multimodal imaging systems and their applications

3. Image-guided interventions and therapies

4. Optical imaging and fluorescence microscopy

5.  Positron emission tomography (PET) and single-photon emission computed tomography (SPECT)

6. Magnetic resonance imaging (MRI) and spectroscopy (MRS)

7. Computed tomography (CT) and X-ray imaging

8. Design and synthesis of molecular probes and nanoprobes in molecular imaging

9. Targeting capabilities of molecular and nano-probes

10. Biodistribution and pharmacokinetics of molecular and nano-probes

11. Molecular probes and nanoprobes for disease monitoring and therapeutic evaluation

• Topic 2: In Vitro Diagnostics

1. Biomarker discovery and validation

2. Point-of-care testing (POCT) devices and technologies

3. Biosensors and nanotechnology in diagnostics

4. Next-generation sequencing (NGS) applications in diagnostics

5. Automation and digital pathology

6. Quality control and standardization in diagnostics

• Topic 3:  Micro and Nano Technologies

1. Lab-on-a-chip and microfluidic systems for diagnostics

2. Micro and nanofabrication techniques

3. Microfluidic chips

4. Micro and nanofluidics

5. Micro total analysis systems (μTAS)

6. Organ-on-a-chip technologies

7. Nanomaterials for diagnosis and disease treatment

• Topic 4: Neuroimaging

1. Functional MRI (fMRI) and its applications in neuroscience

2. Diffusion tensor imaging (DTI) and tractography

3. Electroencephalography (EEG) and magnetoencephalography (MEG)

4. Neuroimaging in psychiatric disorders and neurology

5. Advanced image analysis and machine learning in neuroimaging

6. Neurofeedback and real-time neuroimaging applications

• Topic 5: Biomedical Engineering

1. Design and development of medical devices

2. Biomedical materials and biocompatibility

3. Development of new biomaterials for medical implants and devices

4. Surface properties of biomaterials for improved tissue integration

5. Biomaterials for drug delivery systems

6. Biomechanics and biomechanical modeling

7. Tissue engineering and regenerative medicine

8. Wearable and implantable biomedical devices

9. Biomedical signal processing and analysis

10. Medical robotics and automation

11. 3D bioprinting materials for biomedical applications

• Topic 6: Bioinformatics

1. Genomic data analysis and interpretation

2. Proteomics and systems biology

3. Computational methods in drug discovery

4. Bioinformatics tools for clinical decision support

5. High-performance computing in bioinformatics

6. Data integration and knowledge discovery in bioinformatics

7. Privacy and security in biomedical data management

8. Telemedicine and remote patient monitoring

9. Health informatics and electronic health records (EHRs)

10. Mobile health (mHealth) applications and devices

11. Precision medicine and personalized healthcare

12. Artificial intelligence (AI) and machine learning in healthcare

13. Data-driven clinical research and outcomes analysis

14. Health policy and healthcare management

Committees

Honorary Chairs

• Jie Tian, Institute of Automation, Chinese Academy of Sciences, China
• Shu-Hong Yu, University of Science and Technology of China, China
• Patrick Kwan, Monash University, Australian
• Yiping Zhao, University of Georgia, United States of America

General Chairs

• Zhongliang Wang, Xidian University, China
• Bo Hu, Xidian University, China
• Dmitriy Klyuyev, Karaganda Medical University, Kazakhstan
• Bruno Figadere, Paris-Saclay University, France

Publication Chairs

• Duyang Zang, Northwestern Polytechnical University, China
• Yi Zhang, Xidian University, China

Program Chairs

• Fei Li, Xi’an Jiaotong University, China
• Shouping Zhu, Xidian University, China

Organizing Committee Chairs

• Xueli Chen, Xidian University, China
• Zhouxiang Ji, Xidian University, China

Program Committee

• Xu Cao, Xidian University, China
• Xiaoxia Hu, Xidian University, China
• Nan Xiang, Southeast University, China
• Gregoire Prevost, CIPREVO, France
• Alex Maciuk, Paris-Saclay University, France
• Gerard Bastian, Women Relief Hospital, France
• Maofeng Zhang, Hefei University of Technology, China
• Yupan Wu, Northwestern Polytechnical University, China
• Shijian Liang, Guangzhou Betop Scientific Ltd., China
• Alina Ogizbayeva, Karaganda Medical University, Kanzakhstan
• Ying Zhao, Xi’an Lianchuang Biopharmaceutical Incubator Ltd., China

Scientific Committee

• Pelta Juan, Université d'Evry Val d'Essonne, France
• Peng Zhang, University of Cincinnati, United States of America
• Hongwei Qin, University of Alabama, United States of America
• Jiang Yang, Sun Yat-Sen University, China
• Guoqing Hu, Zhejiang University
• Yukun Ren, Harbin Institute of Technology, China
• Chengjun Huang, Institute of Microelectronics, Chinese Academy of Sciences, China
• Chunyang Xiong, Peking University, China
• Jianzhen Ou, RMIT University, Austrialian
• Yang Lu, Hefei University of Technology, China
• Li Shang, Northwestern Polytechnical University, China

Local Committee

• Langlang Yi, Xidian University, China
• Pengju Yin, Hebei University of Engineering, China
• Bai Song, ASI Global, China
• Wanting Lin, ASI Global, China
• Hongxia Li, ASI Global, China
• Yingli Shen, Xidian University, China
• Yibo Wang, Xidian University, China
• Sijia Wu, Xidian University, China
• Lei Zhao, Xidian University, China
• Chen Chen, Xidian University, China
• Zhongda Wang, Xidian University, China
• Minghui Liang, Xidian University, China

Contact

All questions about submissions should be emailed to conf-papers@outlook.com